Company Filing History:
Years Active: 2006-2011
Title: Richard Newmark: Innovator in Anemia Treatment
Introduction
Richard Newmark is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of blood disorders. With a total of 2 patents, his work focuses on innovative methods to address anemia.
Latest Patents
Newmark's latest patents include a method of treating anemia by administering IL-1ra. This invention relates to methods of treating a blood disorder in a mammal using an interleukin-1 (IL-1) inhibitor. Additionally, it encompasses methods that combine an IL-1 inhibitor, a TNF inhibitor, and an erythropoietin (EPO) receptor agonist. The invention also details compositions that include an IL-1 inhibitor, as well as combinations of an IL-1 inhibitor, a TNF inhibitor, and an EPO receptor agonist.
Career Highlights
Richard Newmark is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on groundbreaking research and development in the medical field.
Collaborations
Newmark has collaborated with notable colleagues such as Jonathan Kay and Dorothy McCabe. Their combined expertise has contributed to advancements in the treatment of anemia and related blood disorders.
Conclusion
Richard Newmark's innovative work in the treatment of anemia showcases his dedication to improving medical therapies. His patents reflect a commitment to advancing healthcare solutions for blood disorders.